NCT06624189
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Enrolling by Invitation
Not specifiedAges 18+ObservationalNYU Langone HealthInvestigator-initiated
~1,300 participants
Updated 2026-02-27 on ClinicalTrials.gov
What's tested:Auto-pended bot liver ultrasound order
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound
Measured over Day 1
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Saul Blecker · PRINCIPAL_INVESTIGATOR · NYU Langone Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
cirrhosis diagnosis,
6 months or more after since most recent imaging.
Exclusion
previous liver transplant,
HCC diagnosis,
receiving hospice care,
completed external imaging in the past 6 months.
What this trial measures
- Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver UltrasoundDay 1